Fate Therapeutics
FATE
FATE
74 hedge funds and large institutions have $101M invested in Fate Therapeutics in 2017 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 18 increasing their positions, 22 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
2.93% less ownership
Funds ownership: 64.28% → 61.35% (-2.9%)
18% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 22
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1K
Holders
74
Holding in Top 10
1
Calls
–
Puts
$1K
Top Buyers
| 1 | +$1.08M | |
| 2 | +$496K | |
| 3 | +$367K | |
| 4 |
6CM
683 Capital Management
New York
|
+$359K |
| 5 |
Neuberger Berman Group
New York
|
+$330K |
Top Sellers
| 1 | -$3.02M | |
| 2 | -$1.49M | |
| 3 | -$1.27M | |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
-$1.09M |
| 5 |
Renaissance Technologies
New York
|
-$352K |